Fig. 3From: Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical studyKaplan-Meier plots of (a, c) disease-free survival (DFS) and (b, d) overall survival (OS) in the CHIP and IV groups stratified by the MMR status. CHIP chemotherapeutic hyperthermic intraperitoneal perfusion; IV chemotherapy alone; dMMR deficient mismatch repair; pMMR proficient mismatch repairBack to article page